Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer

Oral Oncol. 2005 Jan;41(1):97-8. doi: 10.1016/j.oraloncology.2004.03.002.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Genes, erbB-2
  • Humans
  • Salivary Gland Neoplasms / drug therapy*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Trastuzumab